HOME >> MEDICINE >> NEWS
PBS stops growing

Newly released Federal Government figures have confirmed that spending on the Pharmaceutical Benefits Scheme (PBS) is flat-lining.

Official Government data from Medicare Australia (formerly the Health Insurance Commission) shows that PBS spending in April declined by 8.4 percent, the largest month fall since 1994 and one of the largest in the 60-year history of the scheme.

It means that over the 2005-06 financial year to date, PBS spending as recorded by Medicare Australia has increased by only 1.6 percent, far below the inflation rate of 3 percent. This means it is actually falling in real terms.

Spending has fallen in eight of the past 15 months a pattern which is unique in the scheme's history. According to the nation's peak body for the innovative pharmaceutical industry, Medicines Australia, the key questions for stakeholders and Government must be: what is the impact on patients and what are the flow-on effects for other parts of the health budget?

On top of Federal Budget figures from earlier this month, this further confirmation of the scheme's reduced growth means that any additional reform must be considered in the context of the very significant reduction in growth, patient access to medicines and the very large number of medicines now coming off patent.

"Any new reform proposals must be developed in consultation with all stakeholders against the backdrop of a declining PBS and an ageing population where the first priority must be patient access to new medicines," said the Chief Executive Officer of Medicines Australia, Kieran Schneemann.

"The PBS is an investment in health outcomes, not a savings tool. Growth in the PBS will not exceed the inflation rate any time soon.

"Patent expiries plus a series of Government measures, principally the increased co-payment and the 12.5 percent savings measure introduced to reduce the price of generics, have had a major effect," Mr Schneemann said.


'"/>

Contact: Paul Chamberlin
041-923-3989
Research Australia
29-May-2006


Page: 1

Related medicine news :

1. Trial stops after stroke and mortality significantly reduced by blood
2. Anti-fungal drug stops blood vessel growth
3. Natural protein stops deadly human brain cancer in mice
4. Insulin receptor stops progression of Alzheimers disease
5. When a childs heart stops, onset time of abnormal rhythms is crucial
6. RNA interference stops colon cancer spread in mice
7. Surgical plugs in ears bone stops strange form of severe dizziness
8. Patient choice stops at inhaled insulin
9. New compound stops brain cell degeneration in Alzheimers disease
10. New blood transplant method stops fatal side effect, Stanford study finds
11. Study shows new imaging tracer clarifies cause of chest pain up to 30 hours after pain stops

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... (PRWEB) , ... February 09, 2016 , ... ... faculty and staff helped give free oral screenings to 150 children in kindergarten ... 2016. , The College of Dental Medicine joined Chinese American Dental Society of ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... yet the cause of injury may be one of many possible sources: sports, ... PT Continuing Education Course , Mastering Rehab Solutions for the Complexities of ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... treatment to Medicaid beneficiaries who are diagnosed with autism spectrum disorder (ASD). Beginning ... Autism treatment using applied behavior analysis (ABA) is key to providing effective ...
(Date:2/9/2016)... ... February 09, 2016 , ... URise Products announces today an ... the StandUp Walker. Made entirely in the USA, the StandUp Walker is one ... StandUp Walker’s novel patent-pending design offers 2-in-1 benefits of a stand-assist device ...
(Date:2/9/2016)... , ... February 09, 2016 ... ... and e-book publishing software, in partnership with Snowfall4pod Digital, creators of the ... comprehensive book publishing, content management, global distribution and print-on-demand network. , AVALANCHE ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Ill., Feb. 9, 2016  Landauer, Inc. (NYSE: ... radiation measurement and monitoring, outsourced medical physics services and ... for its fiscal 2016 first quarter ended December 31, ... Fiscal 2016 First Quarter Highlights , Revenue ... first quarter of 2015 , Domestic Radiation Measurement services ...
(Date:2/9/2016)... 2016 QGEN ; ... Abschluss eines Kooperationsvertrags mit 10x Genomics für ... den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology und Bioinformatik ... Prime Standard: QIA) gab heute den Abschluss ... Entwicklung und Förderung umfassender Lösungen in den ...
(Date:2/9/2016)... DIEGO , Feb. 9, 2016 Mast ... novel, clinical-stage therapies for sickle cell disease and heart failure, ... stock and warrants to purchase common stock in an underwritten ... conditions, and there can be no assurance as to whether ... the actual size or terms of the offering.   ...
Breaking Medicine Technology:
Cached News: